Thursday Feb 27
Halozyme Therapeutics (HALO) Announces Quarterly Results
Halozyme Therapeutics released its earnings data on Thursday. The company reported EPS for the quarter, missing the Thomson Reuters consensus estimate of by $0.02, AnalystRatings.NET reports.
Thursday Feb 27
Halozyme Therapeutics Management Discusses Q4 2013 Results - Earnings Call Transcript
Greetings and welcome to the Halozyme Therapeutics Fourth Quarter 2013 Financial Results Call.
Halozyme Therapeutics (HALO) Set to Announce Earnings on Thursday
Halozyme Therapeutics is scheduled to be posting its Q413 quarterly earnings results on Thursday, February 27th.
Halozyme Therapeutics To Present At The Cowen And Company 34th Annual Healthcare Conference
The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com , and a recording will be made available for 90 days following the event.
Halozyme to Host Fourth Quarter and 2013 Year-End Financial Results Conference Call
Halozyme Therapeutics, Inc. will webcast its Quarterly Update Conference Call for the fourth quarter and full year 2013 on Thursday, February 27, 2014 at 4:30 p.m. ET/1:30 p.m. PT.
Halozyme Therapeutics Announces Closing Of Public Offering Of Common...
Halozyme intends to use the net proceeds from this offering to fund research and development of proprietary programs, including the potential acceleration of the PEGPH20 program, and for other general corporate purposes.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Micron Technology Inc....
Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Halozyme Therapeutics, Inc. and Micron Technology Inc. .